
Marco Lobba, PhD
CEO and Co-founder
CatenaBio
Marco Lobba obtained his PhD from the University of California Berkeley and was a student in the labs of Nobel Laureate Jennifer Doudna and Matthew Francis, Emeritus Chair of the Berkeley Department of Chemistry. In addition, he holds a bachelor’s degree in from Pomona College.
With his educational foundation rooted at the intersection of chemistry, molecular biology and gene editing, Dr. Lobba co-founded CatenaBio to address the pressing challenge of delivering targeted protein therapeutics.
His expertise in protein conjugation has helped advance innovative treatments, such as CRISPR-based editors and cell-based therapies.
Dr. Lobba’s academic background and experience at UC Berkeley have shaped his vision for revolutionizing precision medicine and developing therapies that were previously unimaginable.